Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

An Indian doctor examines a X-ray picture of a tuberculosis patient. Photo: Channi Anand / AP

A shorter nine-month course of antibiotics might be just as effective in fighting multi-drug-resistant tuberculosis (MDR TB) as the current two-year standard, according to early results from an international clinical trial, per the New York Times. The trial saw a 78% success rate, compared with 81% for the two-year treatment.

Why it matters: Each year, nearly 500,000 people become sick with MDR TB, leading to about 200,000 deaths, according to the Centers for Disease Control and Prevention. A shorter medication regime would benefit the infected populace, which is centered in the developing world.

Current treatments: "Patients with even uncomplicated tuberculosis must take four drugs a day for six months. Treating drug-resistant tuberculosis can require in-hospital intravenous infusions and toxic second-line antibiotics that may cause nausea, deafness, liver damage and other side effects that lead patients to drop out of treatment," the NYT piece stated.

Limitations: Trials tend to show a higher rate of success than real-life scenarios, likely due to the increased scrutiny given during the trials, the researchers said.

"Unlike drug-sensitive TB, which can be treated effectively and cured with the current standard of care, treatment outcomes for MDR-TB are poor, with less than half of cases having successful outcomes with no more than one in 10 MDR-TB patients being effectively identified and treated," according to the study, conducted by the International Union Against Tuberculosis and Lung Disease and UCL.

Go deeper

Updated 3 hours ago - World

Mexican President López Obrador tests positive for coronavirus

Mexico's President Andrés Manuel López Obrador during a press conference at National Palace in Mexico City, Mexico, on Wednesday. Photo: Ismael Rosas/Eyepix Group/Barcroft Media via Getty Images

Mexican President Andrés Manuel López Obrador announced Sunday evening that he's tested positive for COVID-19.

Driving the news: López Obrador tweeted that he has mild symptoms and is receiving medical treatment. "As always, I am optimistic," he added. "We will all move forward."

3 hours ago - Politics & Policy

Sarah Huckabee Sanders to run for governor of Arkansas

Sarah Huckabee Sanders at FOX News' studios in New York City in 2019. Photo: Steven Ferdman/Getty Images

Former White House press secretary Sarah Huckabee Sanders will announce Monday that she's running for governor of Arkansas.

The big picture: Sanders was touted as a contender after it was announced she was leaving the Trump administration in June 2019. Then-President Trump tweeted he hoped she would run for governor, adding "she would be fantastic." Sanders is "seen as leader in the polls" in the Republican state, notes the Washington Post's Josh Dawsey, who first reported the news.

Coronavirus has inflamed global inequality

Illustration: Aïda Amer/Axios

History will likely remember the pandemic as the "first time since records began that inequality rose in virtually every country on earth at the same time." That's the verdict from Oxfam's inequality report covering the year 2020 — a terrible year that hit the poorest, hardest across the planet.

Why it matters: The world's poorest were already in a race against time, facing down an existential risk in the form of global climate change. The coronavirus pandemic could set global poverty reduction back as much as a full decade, according to the World Bank.